The Plaque psoriasis market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage pipeline products will significantly revolutionize the Plaque psoriasis market dynamics.  

DelveInsight’s “Plaque psoriasis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Plaque psoriasis, historical and forecasted epidemiology as well as the Plaque psoriasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. 

Some of the key facts of the Plaque psoriasis Market Report: 

• The Plaque psoriasis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)  
• Psoriasis is a chronic, immune disease that affects the skin. It occurs when the immune system sends out faulty signals that speed up the growth cycle of skin cells 
• According to Wilson et al., About 80 to 90 percent of people living with psoriasis experience plaque psoriasis (Psoriasis vulgaris) 
• According to Columbo et al., in Italy, Psoriasis is a chronic inflammatory, immune-mediated skin disorder that affects 1.5–1.8 million people 
• Key Plaque psoriasis Companies: Pfizer, AstraZeneca, Novartis Pharmaceuticals, Dermavant Sciences, Inc., and others 
• Key Plaque psoriasis Therapies: Secukinumab, PF-06700841, TINEFCON, Certolizumab pegol, and others 
• The Plaque psoriasis epidemiology based on gender analyzed that males are slightly more affected with Plaque Psoriasis as compared to females

Request a sample for the Plaque psoriasis Market Report 

Key benefits of the Plaque psoriasis Market report:

1. Plaque psoriasis market report covers a descriptive overview and comprehensive insight of the Plaque psoriasis Epidemiology and Plaque psoriasis market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. The Plaque psoriasis market report provides insights on the current and emerging therapies.
3. Plaque psoriasis market report provides a global historical and forecasted market covering drug outreach in 7MM.
4. The Plaque psoriasis market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Plaque psoriasis market.

Discover more about therapies set to grab major Plaque psoriasis market share @ Plaque psoriasis market forecast 

Plaque psoriasis Overview

Psoriasis, a skin disorder, may cause itchiness and discomfort. Plaque psoriasis, the most common type, causes thick, scaly patches of skin. Plaque psoriasis also known as Psoriasis vulgaris is considered as an autoimmune disease. Plaque psoriasis depends on heredity and trigger response of immune system.

Treatment options for Plaque Psoriasis include: Topical medications like, anthralin, corticosteroids, vitamin A, and vitamin D, light therapy, systemic drugs like acitretin, cyclosporine, and methotrexate, and Biologic drugs like, adalimumab (Humira), brodalumab (Siliq), etanercept(Enbrel), guselkumab (Tremfya), infliximab (Remicade), ixekizumab (Taltz), risankisumab-Raza (Skyrizi), secukinumab (Cosentyx), and ustekinumab (Stelara). Topical therapies are considered first-line treatment in managing plaque psoriasis (PSO). Plaque psoriasis is of the following types:

• Small plaque psoriasis  
• Large plaque psoriasis
• Unstable plaque psoriasis
• Chronic, stable plaque psoriasis

Plaque psoriasis Symptoms  

The Plaque psoriasis symptoms include –

• Dry, itchy, raised skin patches
• Abnormal nail growth
• Drop-shaped
• Scaling spots on the trunk, arms or legs

Plaque psoriasis Epidemiology Segmentation:

The Plaque psoriasis market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

• Total Prevalence of Plaque psoriasis
• Prevalent Cases of Plaque psoriasis by severity
• Gender-specific Prevalence of Plaque psoriasis
• Diagnosed Cases of Episodic and Chronic Plaque psoriasis 

Plaque psoriasis Market  

The dynamics of the Plaque psoriasis market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as tapinarof cream, PF-06700841, and others during the forecasted period 2019-2032. 

Download the report to understand which factors are driving Plaque psoriasis epidemiology trends @ Plaque psoriasis Epidemiological Insights 

Plaque psoriasis Therapies

• Secukinumab
• PF-06700841
• TINEFCON
• Certolizumab pegol

Plaque psoriasis Key Companies  

• Pfizer
• AstraZeneca
• Novartis Pharmaceuticals
• Dermavant Sciences, Inc

Scope of the Plaque psoriasis Market Report

• Study Period: 2019–2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Plaque psoriasis Companies: Pfizer, AstraZeneca, Novartis Pharmaceuticals, Dermavant Sciences, Inc, and others
• Key Plaque psoriasis Therapies: Secukinumab, PF-06700841, TINEFCON, Certolizumab pegol, and others
• Therapeutic Assessment: Plaque psoriasis current marketed and Plaque psoriasis emerging therapies
• Migraine Market Dynamics:  Plaque psoriasis market drivers and barriers 
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
• Unmet Needs, KOL’s views, Analyst’s views, Plaque psoriasis  Market Access and Reimbursement

Table of Contents 

1. Plaque psoriasis Market Report Introduction

2. Executive Summary for Plaque psoriasis

3. SWOT analysis of Plaque psoriasis

4. Plaque psoriasis Patient Share (%) Overview at a Glance

5. Plaque psoriasis Market Overview at a Glance

6. Plaque psoriasis Disease Background and Overview

7. Plaque psoriasis Epidemiology and Patient Population

8. Country-Specific Patient Population of Plaque psoriasis 

9. Plaque psoriasis Current Treatment and Medical Practices

10. Plaque psoriasis Unmet Needs

11. Plaque psoriasis Emerging Therapies

12. Plaque psoriasis Market Outlook

13. Country-Wise Plaque psoriasis Market Analysis (2019–2032)

14. Plaque psoriasis Market Access and Reimbursement of Therapies

15. Plaque psoriasis Market drivers

16. Plaque psoriasis Market barriers

17.  Plaque psoriasis Appendix

18. Plaque psoriasis Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

To know more about Plaque psoriasis treatment, visit @ Plaque psoriasis Medications

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/